EGFR gene mutations tested for

MolecularAlso known as: EGFR gene Mut Tested Bld/TN/A

Identifies specific mutations in the EGFR gene from blood or tissue samples.

Normal Range
Consult your provider
N/A
Abnormal Levels
Consult your provider
Specimen Type
Blood

Why This Biomarker Matters

EGFR mutations guide targeted cancer therapy selection. Knowing your mutation status enables personalized treatment with drugs most likely to work for your specific cancer.

Overview

This test identifies specific mutations in the EGFR (epidermal growth factor receptor) gene from blood or tissue samples. EGFR mutations are commonly found in certain lung cancers and can determine which targeted therapies will be most effective. Different mutations respond differently to specific medications called EGFR inhibitors. Testing for EGFR mutations is crucial for cancer patients to guide treatment selection, predict drug response, and optimize outcomes. This genetic information helps oncologists personalize cancer treatment plans.

Technical Information (LOINC Codes)

Standardized laboratory codes for this biomarker

21666-3Primary
EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal